In Vitro Activity of Dalbavancin against Refractory Multidrug-Resistant (MDR) <i>Staphylococcus aureus</i> Isolates

The high prevalence of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) infections, always treated with vancomycin and daptomycin, has led to the emergence of vancomycin-intermediate (VISA), heteroresistant vancomycin-intermediate (hVISA) and daptomycin non-susceptible (DNS) <i>S. aureus</i...

Descrición completa

Detalles Bibliográficos

Principais autores:	Dafne Bongiorno, Lorenzo Mattia Lazzaro, Stefania Stefani, Floriana Campanile
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2020-12-01
Series:	Antibiotics
Assuntos:	<i>Staphylococcus aureus</i> MDR-MRSA dalbavancin bactericidal activity refractory clones
Acceso en liña:	https://www.mdpi.com/2079-6382/9/12/865
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!